Suzhou MedicalSystem Technology Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Suzhou MedicalSystem Technology Co., Ltd. carries a market capitalization of 6.70B, placing it among publicly traded companies globally. Its enterprise value stands at 4.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.70B |
| Enterprise Value | 4.81B |
Share Statistics
Suzhou MedicalSystem Technology Co., Ltd. currently has 306.28M shares outstanding.
| Shares Outstanding | 306.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 13.97, and the price-to-book ratio stands at 50.04.
| PE Ratio | N/A |
| PS Ratio | 13.97 |
| PB Ratio | 50.04 |
| P/TBV Ratio | 6.99 |
| P/FCF Ratio | 33.46 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 14.01 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 25.03 |
Financial Position
Suzhou MedicalSystem Technology Co., Ltd. maintains a current ratio of 2.51, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 36.30, indicating elevated leverage, while an interest coverage ratio of -1.66 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.51 |
| Quick Ratio | 0.90 |
| Debt / Equity | 36.30 |
| Debt / EBITDA | -4.28 |
| Interest Coverage | -1.66 |
Financial Efficiency
| Return on Equity (ROE) | -95.43 |
| Return on Assets (ROA) | -7.20 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 11.43 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.45 |
Taxes
Over the trailing twelve months, Suzhou MedicalSystem Technology Co., Ltd. has paid 21.16M in income taxes, reflecting an effective tax rate of 11.22.
| Income Tax | 21.16M |
| Effective Tax Rate | 11.22 |
Stock Price Statistics
Suzhou MedicalSystem Technology Co., Ltd.'s stock has gained approximately 36.56716% over the past 52 weeks. The 50-day moving average sits at 19.15, while the 200-day moving average is 16.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | 36.56716% |
| 50-Day Moving Average | 19.15 |
| 200-Day Moving Average | 16.29 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Suzhou MedicalSystem Technology Co., Ltd. generated 342.99M in revenue and converted that into -174.81M in net income, yielding earnings per share of -0.58. EBITDA reached -71.10M, while operating income came in at -71.10M.
| Revenue | 342.99M |
| Gross Profit | 125.07M |
| Operating Income | -71.10M |
| Pretax Income | -151.31M |
| Net Income | -174.81M |
| EBITDA | -71.10M |
| EBIT | -71.10M |
| Earnings Per Share (EPS) | -0.58 |
Balance Sheet
Suzhou MedicalSystem Technology Co., Ltd. holds 300.18M in cash and equivalents against 303.98M in total debt, resulting in a net debt position of -74.78M. Total book value stands at 95.79M, with working capital of 501.78M providing operational flexibility.
| Cash & Cash Equivalents | 300.18M |
| Total Debt | 303.98M |
| Net Debt | -74.78M |
| Equity (Book Value) | 95.79M |
| Book Value Per Share | 0.32 |
| Working Capital | 501.78M |
Cash Flow
After subtracting -143.23M in capital expenditures, free cash flow totaled -143.23M - equivalent to -0.49 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -143.23M |
| Free Cash Flow | -143.23M |
| FCF Per Share | -0.49 |
Margins
Suzhou MedicalSystem Technology Co., Ltd. operates with a gross margin of 36.46, reflecting its pricing power and cost economics. The operating margin of -20.73 and net profit margin of -50.97 provide insight into operational efficiency.
| Gross Margin | 36.46 |
| Operating Margin | -20.73 |
| Pretax Margin | -44.11 |
| Profit Margin | -50.97 |
| EBITDA Margin | -20.73 |
Dividends & Yields
The company's payout ratio of -8.05 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.05 |
| Dividend Yield | N/A |
| Payout Ratio | -8.05 |
| Shareholder Yield | 3.93 |
| FCF Yield | 2.99 |
Stock Splits
Suzhou MedicalSystem Technology Co., Ltd.'s most recent stock split took place on July 7, 2023 with a 10:13 split ratio.
| Last Split Date | 7/7/2023 |
| Split Ratio | 10:13 |
Scores
Suzhou MedicalSystem Technology Co., Ltd. posts an Altman Z-Score of 7.26, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.26 |